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Rapid Purification and Characterization of Human Platelet Glycoprotein V: The Amino Acid Sequence Contains Leucine-Rich Repetitive Modules as in Glycoprotein Ib
By Takeshi Shimomura, Kingo Fujimura, Shuji Maehama, Motoyoshi Takemoto, Kenji Oda, Tetsuro Fujimoto, Rieko Oyama, Masami Suzuki, Keiko Ichihara-Tanaka, Koiti Titani, and Atsushi Kuramoto Glycoprotein V (GPV) is a membrane-associated, 82 Kd platelet glycoprotein that is hydrolyzed during thrombin activation to yield 69 Kd fragment. We have developed a rapid and simple method for isolation of t h e protein from platelet extracts using a combination of gel permeation, anion-exchange. and lectin affinity chromatography. The partial amino acid sequence was determined by analysis of peptides generated by digestion of t h e S-carboxyamidomethylated protein with Achromobacter protease I or cyanogen bromide. The sequence shows a remarkable periodicity of leucine residues, which is homologous to the consensus sequence of a highly diversified protein super-LYCOPROTEIN (GP) V is the only platelet mem-G brane glycoprotein so far identified that is specifically hydrolyzed during activation by
In patients with
Bernard-Soulier syndrome, a rare inherited bleeding disorder, this glycoprotein is absent, as are GPIb and GPIX.3-6 Platelets from these patients can be activated by thrombin, but a long lag time is required to start the a g g r e g a t i~n .~ Binding of a-thrombin to a high or moderate affinity site located in the glycocalycin portion of GPIb is considered to be a step necessary for platelet a~tivation.'.~ However, measured equilibrium binding of a-thrombin to platelets appears to be unrelated to platelet activation," and binding of thrombin inactivated by blocking the active site causes no activation. GPV has been proposed to be a thrombin receptor." However, rate or extent of GPV hydrolysis seems not to be correlated directly with platelet activation.I2 In addition, blocking of GPV hydrolysis by anti-GPV antibodies does not prevent thrombin tim mu la ti on.'^ Therefore, the role of GPV in platelet activation by thrombin remains to be elucidated.
Knowledge of the structure of the GPV molecule is essential for understanding the mechanisms involved in its interaction with thrombin and in disorders related to this protein. In this regard, we established a rapid and simple purification procedure by a modification of the method reported by Berndt and Phillips,14 Zafar and W a l~, '~. '~ or Bienz et all3 and determined the partial amino acid sequence with the purified protein.
MATERIALS AND METHODS
Columns and buffers. Superose 12 HR 10/30 gel permeation and Mono Q HR 5/5 anion exchange columns, and wheat germ agglutinin Sepharose 6MB were purchased from Pharmacia (Uppsala, Sweden). All the reagents used throughout the isolation procedure are of high performance liquid chromatography (HPLC) grade.
Fresh healthy donor platelets were prepared using Hemonetics 30s (Haemonetics Corp, MA) and used within 1 day of venipuncture. We obtained approximately 5 x 10" platelets from a single donor. Donor platelets were centrifuged at 120 g for 15 minutes at rmm temperature to remove the contaminated red blood cells. Acid-citrated dextrose (ACD) anticoagulant (1/6 volume) was added to platelet-rich plasma and centrifuged at Purification of GPK family with a common repetitive module. Thrombin cleavage site w a s determined to be located at t h e C-terminal region of GPV by analysis of t h e products separated by sizing and reversed-phase high performance liquid chromatography. By lectin blot analysis, t h e existence of mucintype carbohydrate chains w a s indicated, as well as t h e existence of asparagine-linked carbohydrate chains shown by the amino acid sequence analysis. From these data, we report a structural model of GPV that is analogous to glycoprotein Ib. 0 1990 b y The American Society of Hematology.
1,200g
for 15 minutes to sediment platelets, which were subsequently washed three times in 10 mmol/L HEPES, pH 7.6 (1 mmol/L in EDTA, 0.15 mol/L in NaCI). GPV was extracted from platelet plasma membrane by incubating platelets (2 x lo9 platelets/ mL) at 37OC for 20 hours in 10 mmol/L HEPES, pH 7.6 (1 mmol/L in EDTA, 0.3 mol/L in NaCI, 1 mmol/L in p-aminophenylmethylsulphonyl fluoride). The extract from two donors' platelets was brought to 40% saturation with solid ammonium sulfate, stirred for 30 minutes and centrifuged, and then brought to 60% saturation with ammonium sulfate and treated similarly. The pellet precipitated in 60% saturation was taken up in a minimum volume (10 mL) of 50 mmol/L potassium phosphate, pH 6.8 (1 mmol/L in EDTA) (buffer A), dialyzed against the same buffer for about 4 hours at 4OC, concentrated with hygroscopic polymer (Aquacides, Calbiochem, USA) in a dialyzing bag, and clarified by centrifuging at 10,OOOg for 30 minutes at 4OC for the subsequent purification process.
We applied 500 pL of the dialyzed sample to a Superose 12 column equilibrated with buffer A. The column was eluted with the same buffer at a flow rate of 0.5 mL/min, and 0.5 mL fractions were collected. The whole sample was separated by multiple runs. The GPV-rich fractions were pooled and then directly applied to a Mono
Cleavage at methionyl residues was carried out with 2% cyanogen bromide in 70% formic acid at room temperature as described by Gross." The native GPV was digested with thrombin in 100 mmol/L sodium phosphate. pH 7.4 . at 37°C for 30 minutes. Peptides were partially separated by HPLC on TSK gel columns connected in series (G3000SW-G200OSW,each 7.5 x 600 mm.ToyoWa. Japan) in 6 mol/l. guanidine HCI/IO mmol/L sodium phosphate. pH 6.8. Further purification of peptides was achieved by reversed-phase HPLC on a column of Cosmosil 5C4-300 (4 x I50 mm. Nacalai Tesque) using an acetonitrile gradient made in dilute aqueous trifluoroacetic acid.
Amino acid compositions were determined with a Hitachi L-8500 Amino Acid Analyizr (Tokyo, Japan) or by the phenylisothiocyanate Fdman degradations were done in an Applied Aliquots (5 pg) of GPV and GPV treated with thrombin as described above were incubated with or without Arfhrohacrer neuraminidase (5 U/mL; Bochringer Mannheim Biochemicals. Yamanouchi. Tokyo. Japan) in 50 mmol/L sodium acetate bulTer. pH 5.0. at 37OC for IS hours. They were then applied to SDS-PAGE (8%). blotted onto a nitrocellulose membrane and stained with horseradish peroxidase-conjugated peanut agglutinin (PNA; Seikagaku-Kogyo. Tokyo, Japan) following manufacturer's instructions. At the same time. the binding to the blot of the primary rabbit antibody against GPV was detected with '-"l-protein A. followed by autoradiography. k c f i n 6/01 analysis. dilute aqueous trifiuoroacetic acid. A single sharp peak was obtained at 45% of acetonitrile concentration (data not shown). Purified GPV showed multiple forms, ranging from 5.6 to 6.6 on isoelectric focusing (Fig 2B) . All these characteristics. including 82 Kd carbohydrate-rich protein, thrombin susceptibility. and pl. are concomitant to those previously reported" for GPV. Yields of GPV at various purification steps are summarized in Table 1 .
RESULTS

Puri
Amino ucids composition. Amino acid composition of CMA-GPV is shown in Table 2 on a molar basis. The calculation was based on the data of Berndt and Phillips" that polypeptide moiety comprises 52% of the total mass of GPV (mol wt of 82 Kd). corresponding to a protein with mol wt of 43 Kd. GPV appears to have some characteristic enrichment of leucine residues.
Generution of peptides. A digest of the CMA-protein (about 2 nmol each) with Achromohuctcr protease I (Fig 3A. B. and C) or cyanogen bromide (data not shown) was separated by size exclusion HPLC. and pooled fractions were further purified by reversed-phase HPLC. Two primary sets of peptides, KI-K7 and MI-M8 (cyanogen bromide fragments). were thus isolated and subjected to amino acid and 
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sequence analyses. The digest of the intact protein with thrombin was separated in a similar manner as described above by a combination of size-exclusion (Fig 4) and reversed-phase HPLC (data not shown). Two fragments. Thl and Th2, were isolated. Fragment Thl seemed to be identical to the previously reported GPVfl on the basis of the apparent mol wt (69 Kd).
Sequence analysis. Sequence analysis of the intact protein (100 pmol) yielded no phenylthiohydantoins (PTHs) in three cyclcs of Edman degradations. indicating that the amino terminus of the protein is blocked. The amino- terminal sequences of seven K peptides (Kl-7), eight M peptides (Ml-8), and two Th peptides (Thl and 2) are shown in Table 3 . The link of K5 to K6 was established by analysis of M2. Peptide M8 was considered to be included within the sequence of K5. Peptides M3 and M4 were initially isolated as a mixture, but could be differentiated by referring to the sequence of Th2 that provided one of the two sequences. The cause of unexpected cleavage between Asp-Ser within the Th2 peptide is unknown. The amino terminus of Thl was blocked, clearly indicating that GPVfl (69 Kd fragment of GPV) was derived from the N-terminal region of GPV, and the thrombin cleavage site was located in a close proximity to the C-terminus of GPV. We have not yet obtained the entire sequence of GPV, but most of peptides (Kl, K2, K4, K5-K6, M1, M6, and M7) show a remarkable periodicity of leucine residues (Fig 5) . This periodicity appears to be homologous to that observed with a group of proteins, including integral membrane or membrane-associated proteins (GP Ib,22-24 adenylate cyclase of yeast,2s toll gene product,26 ~haoptin,~') proteoglycans or connective tissue proteins (PGI,28 PGII,29 fibrom~dulin,~~), and plasma proteins (LRP,3' RA13*) (Fig 6) . Aligning the peptides so as to correspond to the consensus sequences reported in this article made it possible to obtain highly homologous tandem repeats and to propose consensus sequence of GPV. GPV is likely to contain 10 or more of these repeats (Fig 5 ) .
After treatment of purified GPV with neuraminidase, the apparent mol wt was reduced to 70 Kd (Fig 7) and it 
SS-EAPVHPALAP-S-EP-V N-blocked GPPRPAADSS-EAPVHPALAP-S-EP-V-AQD
Three sets of peptides are prefixed by K, M, and Th. respectively.
Sequences written in lower-case letters indicate tentative identification.
Those not identified are shown by dashes. Asterisks indicate potential asparginelinked glycosylation sites.
cleavaged fragment, GPVfl, seems to bind PNA less intensively than GPV after neuraminidase treatment, in comparison with the intensity of immunoblotted GPVfl, suggesting that the mucin-type carbohydrate chains mostly exist in the C-terminal region of GPV (Fig 8) .
DISCUSSION
In the present study, we attempted to purify the platelet membrane glycoprotein V to homogeneity by modification of the method reported by Berndt and P h i l l i p~'~ or Zafar and W a l~. "~'~ The modification included use of FPLC system at the size-exclusion and anion-exchange chromatography steps and a new lectin-affinity chromatography at the final step, and eliminated the hydroxyapatite and cation-exchange chromatography steps. The previous method^'^"^ required many dialysis steps using various buffers before each chromatography. We used only one buffer system through all chromatographies, and all the procedures can be easily done within 4 days. As to the yield, we can easily purify 200 pg of GPV from 10l2 platelets. This high yield also seems to have an advantage over the method reported by Berndt and Phillips or Zafar and Walz (100 pg from 10l2 platelets), although the yield seems to be dependent on freshness of platelet samples (data not shown) as reported by Berndt and Phillips.I4 The apparent molecular weight, thrombin sensitivity, PI, and amino acid composition of GPV purified in the present study are very similar to those of GPV isolated by the method previously reported.
Bienz et all3 have purified GPVs, a fragment of GPV cleaved by calpain, from platelets sonicated in a buffer containing calcium ion, using wheat germ agglutinin and anion-exchange chromatography." GPVs seems to have almost the same mol wt and PI as GPV purified in the present study. In our purification, there remains a possibility that purified GPV is a fragment generated by calpain. However, in order to activate calpain, it appears that their method consumes a half amount of platelets. Therefore, our method should have an advantage over theirs in terms of the final yield.
Although we have not yet obtained the entire sequence of GPV, most of the peptides analyzed contained homologous leucine-rich repetitive sequences, which are observed with a number of proteins. Schneider et have proposed that these repetitive modules should be common structural features of a novel protein superfamily whose members exert their functions by highly specific protein-protein interactions. For example, PGII and fibromodulin bind to a specific type of collagen and cause inhibitory effects on collagen fibril f~rmation.~'-~' RAI binds to angiogenin or RNase and abolishes both the angiogenic and ribonucleolytic a~t i v i t i e s .~~ Yeast adenylate cyclase has been suggested to bind to the cytosolic side of the cell membrane with the repeat^.^' Drosophila toll gene product plays a role in embryonic dorsal-ventral patterning, hypothetically using the extracellular repeats for the cell adhesion.26 Drosophila chaoptin is an intercellular cytoadhesive protein for photoreceptor cells.27
L J N R T Q~R T V T L S P R L -M I S D S H I S A V
For personal at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From The N-terminal tryptic fragment of GPIba contains seven of these repeats, which appear to contain the binding sites for von Willebrand factor and t h r~m b i n .~' .~~ However, Tanoue et a134 have recently reported that the precise binding sites are located in the C-terminal region of the fragment without the repeats. GPV may also bind to other macromolecules. GPlbP, a major protein phosphorylated under the conditions that increase cytoplasmic concentration of CAMP in platelet^,^^.^' is linked to GPIba by disulfide bonds' and contains one leucine-rich module.24 GPIX forms a complex with GPIb38-40 and has been recently reported to contain one such m o d~l e .~' Therefore, the platelet membrane glycoproteins, which are simultaneously defective in Bernard-Soulier syndrome, all contain more or less the leucine-rich modules. They must have evolved from the same ancestral gene and have some correlations in their functions.
The apparent molecular weight of cyanogen bromide fragment M1 was estimated to be 36 Kd (almost half the mass of GPV) from the elution volume by size-exclusion chromatography (data not shown). The fragment appears to be derived from the C-terminal region of GPV on the basis of the amino acid composition, which contains no homoserine and which contains only one lysyl residue. Therefore, other cyanogen bromide fragments and most K peptides containing more or less the leucine-rich repeats were probably derived from the amino-terminal half of GPV. The sequence of fragment Th2 is very similar to that reported as the Nterminal sequence of GPVfl by Zafar and Walz.I6 However, our data clearly indicate that the N-terminus of the large fragment (Thl) generated by cleavage with thrombin is blocked. We assumed, therefore, that thrombin cleavage site is located in a close proximity to the C-terminus of GPV. From the data described herein, we propose the structural organization of GPV as shown in Fig 8, which shows a remarkable similarity to the structure of GPIbu reported by Titani et a122 and Lopez et aLz3 These findings should be useful for understanding the pathogenesis of Bernard-Soulier syndrome and also the mechanism of thrombin interaction with platelets.
